Wow, this Puretech site is very good news indeed! I haven't seen it before.
So this basically confirms Follica are halfway through human trials (so they probably passed phase IIa).
But as far as I know they were injecting lithium since beginning of the trials, and they came up with injecting FGF-9 only recently.
So what we don't know is if they will continue the trials with FGF9 from Phase IIb, or will they have to start them from Phase I again?
Here, I found that FGF9 was only involved in preclinical trials so far. That's not the good news I think...
So this basically confirms Follica are halfway through human trials (so they probably passed phase IIa).
But as far as I know they were injecting lithium since beginning of the trials, and they came up with injecting FGF-9 only recently.
So what we don't know is if they will continue the trials with FGF9 from Phase IIb, or will they have to start them from Phase I again?
Here, I found that FGF9 was only involved in preclinical trials so far. That's not the good news I think...
[An earlier version of this story indicated that Follica used that protein, Fgf9, in its clinical trial. Olle later clarified that the protein, Fgf9, has only been involved in Follica's preclinical work so far].
Comment